Projects per year
Fingerprint
Dive into the research topics where Gerard Lozanski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma
Gurcan, M. N. (CoPI), Lozanski, G. (CoPI) & Gurcan, M. N. (PI)
05/1/09 → 05/31/19
Project: Research
-
Clonal Hematopoiesis Rates in a Recurrent Venous Thrombosis Population: A Prospective Pilot Study
Haque, T., Lozanski, A., Doong, T. J., Huang, Y., Li, R., Bartosic, A., Landes, K., Lozanski, G., Byrd, J. C. & Wang, T.-F., Jan 1 2026, In: Clinical and Applied Thrombosis/Hemostasis. 32Research output: Contribution to journal › Article › peer-review
Open Access -
Outcomes of patients with chronic lymphocytic leukemia discontinuing covalent Bruton tyrosine kinase inhibitors due to adverse events
Mansour, A. G., Huang, Y., Pemberton, J. P., Alsouqi, A., Kittai, A., Byrd, J. C., Grever, M. R., Miller, C., Lozanski, G., Wiczer, T., Lundberg, J., Rosen, L., Crawford, C., Everhart, T., Moran, M., Lucas, M., Hinton, S., Grantier, C., Hoffman, C. & Reid, M. & 3 others, , 2026, (Accepted/In press) In: Leukemia.Research output: Contribution to journal › Letter › peer-review
-
Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study
Rogers, K. A., Yan, P., Flinn, I. W., Stephens, D. M., Kipps, T. J., Larson, S. M., Martz, L., Chen, X., Wang, H., Hopping, E., Bundschuh, R., Turkoglu, A., Lozanski, G., McGarry, C., Acosta, A., Sechaud, R., Baldoni, D., Chaudhury, A., Whalen, J. & Hassounah, N. B. & 4 others, , Dec 15 2025, In: Clinical Cancer Research. 31, 24, p. 5145-5158 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
Sirenko, M., Lee, S., Sun, Z., Chaligne, R., Loghavi, S., Asimomitis, G., Brierley, C. K., Bernard, E., Cai, S. F., Myers, R. M., Nadorp, B., Sango, J., Lallo, M., Levine, M. F., Domenico, D., Arango Ossa, J. E., Medina-Martinez, J. S., Menghrajani, K., Lasry, A. & Mims, A. S. & 15 others, , Jul 3 2025, In: Cell Stem Cell. 32, 7, p. 1102-1121.e5Research output: Contribution to journal › Article › peer-review
Open Access20 Link opens in a new tab Scopus citations -
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia
Ravikrishnan, J., Diaz-Rohena, D. Y., Muhowski, E., Mo, X., Lai, T. H., Misra, S., Williams, C. D., Sanchez, J. R., Mitchell, A., Satpati, S., Perry, E., Kaufman, T., Liu, C., Lozanski, A., Lozanski, G., Rogers, K. A., Kittai, A. S., Bhat, S. A., Collins, M. C. & Davids, M. S. & 11 others, , Jan 2025, In: Haematologica. 110, 1, p. 78-91 14 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Link opens in a new tab Scopus citations